General description
4-Fluoro-isobutyryl fentanyl, also known as 4-FIBF and p-FIBF, is a fentanyl analog and sold on the illicit market as designer drug. This certified Snap-N-Spike® solution is suitable for use as starting material in calibrators and controls for 4-Fluoro-isobutyryl fentanyl LC/MS or GC/MS testing methods in clinical toxicology, urine drug testing, or forensic analysis applications. This certified solution standard is DEA-exempt, allowing laboratories to place orders without additional regulatory paperwork. For US customers, state specific regulatory requirements may apply.
Legal Information
CERILLIANT is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Cerilliant Corporation
Molecular Weight: 368.49. Empirical Formula: C23H29FN2O. grade: certified reference material. Quality Level: 300. form: liquid. feature: Snap-N-Spike®. /Snap-N-Shoot®. . packaging: ampule of 0.5 . mL. manufacturer/tradename: Cerilliant®. . drug control: estupefaciente (Spain). Decreto Lei 15/93: Tabela IA (Portugal). concentration: 100 . μ. g/mL in methanol. technique(s): gas chromatography (GC): suitable, liquid chromatography (LC): suitable. application(s): forensics and toxicology. format: single component solution. storage temp.: −. 20°C. SMILES string: O: C(N(C1-. @C-. @C-. @N(-. @C-. @C-. @1)CCC2: CC: CC: C2)C3: . @C-. @C: . @C(F)-. @C: . @C-. @3)C(C)C. Pictograms: GHS02,GHS06,GHS08. Signal Word: Danger. Hazard Statements: H225 - H301 + H311 + H331 - H370. Precautionary Statements: P210 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311. Hazard Classifications: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1. Target Organs: Eyes. Storage Class Code: 3 - Flammable liquids. WGK: WGK 2. Flash Point(F): 49.5 °F - closed cup. Flash Point(C): 9.7 °C - closed cup.- UPC:
- 51111603
- Condition:
- New
- HazmatClass:
- Yes
- MPN:
- F-050-0.5ML
- CAS:
- 244195-32-2
- DEA:
- Yes
akash.verma@cenmed.com
(732) 447-1115





